The pair will develop drug-digital therapeutic combinations as a singular product, thus sidestepping reimbursement hurdles linked to individually approved digital therapies.
One CEO said people should be using AI to understand their health much more than they already do.
A headset recently approved by the Food and Drug Administration uses a weak electric current to shock the brain. Some ...
A stick-on gel for plants could one day offer a simple, safe and targeted way to treat diseases and pests. Engineers at the ...
The United Nations Office on Drugs and Crime (UNODC) said Nigeria will no longer be a permissive ground for international ...
Super Patch CEO Jay Dhaliwal on the present and the future of transdermal vitamin and medical patches. Say goodbye to ...
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with ...
CNW/ - The TELUS Health 2026 Drug Data Trends & National Benchmarks Report, released today at the TELUS Health Annual ...
Johnson & Johnson (J&J) is using artificial intelligence to slash by half the time it takes to generate new leads for ...
HONG KONG SAR - Media OutReach Newswire - 10 April 2026 - AilsynBio, an AI-driven drug discovery company, held an ...
Massachusetts Institute of Technology researchers discovered a paradoxical phenomenon in optical physics that could enable a ...
Interesting Engineering on MSN
FDA clears first US trial of wireless brain implant for treatment-resistant depression
A tiny brain implant, no bigger than a blueberry, is moving from lab concept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results